| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/07/2000 | WO2000041514A3 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation |
| 12/07/2000 | WO2000039304A9 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 12/07/2000 | DE19925199A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy |
| 12/07/2000 | DE19924965A1 Preparing an agent for diagnosis or control of microbial infection, useful particularly against Helicobacter, based on identification of essential genes in defective mutants |
| 12/07/2000 | DE19919585A1 Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen Use of Phyllanthus for the treatment of oxidative stress and other symptoms |
| 12/07/2000 | CA2385822A1 Essential gene and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections |
| 12/07/2000 | CA2375855A1 Modulation of gene expression in gastrointestinal inflammation |
| 12/07/2000 | CA2375802A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy |
| 12/07/2000 | CA2375800A1 Vaccine against isa virus |
| 12/07/2000 | CA2375683A1 Il-8 receptor antagonists |
| 12/07/2000 | CA2375657A1 Conformationally constrained backbone cyclized interleukin-6 antagonists |
| 12/07/2000 | CA2375630A1 Antibacterial compounds |
| 12/07/2000 | CA2375348A1 Novel antioxidants, preparation methods and uses |
| 12/07/2000 | CA2375237A1 Method of sterilizing |
| 12/07/2000 | CA2375147A1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 12/07/2000 | CA2374409A1 A variant of c6 .beta.-chemokine leukotactin-1(shlkn-1) with enhanced biological activity |
| 12/07/2000 | CA2374347A1 Screening method for peptides |
| 12/07/2000 | CA2374295A1 Il-8 receptor antagonists |
| 12/07/2000 | CA2374222A1 Cytoskeleton-associated proteins |
| 12/07/2000 | CA2373937A1 Alpha v integrin receptor antagonists |
| 12/07/2000 | CA2373638A1 Adam polynucleotides and polypeptides |
| 12/07/2000 | CA2372250A1 Fimbrial proteins |
| 12/07/2000 | CA2372249A1 Chemokine receptor ccr3 antagonists |
| 12/07/2000 | CA2372246A1 Human tumor necrosis factor receptor tr10 |
| 12/07/2000 | CA2372233A1 Bicyclic oxazolidinones as antibacterial agent |
| 12/07/2000 | CA2371033A1 Injectable anesthetic formulation |
| 12/07/2000 | CA2370141A1 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 12/07/2000 | CA2368192A1 Preparations for the application of antiseptic agents to the interior of the human or animal body |
| 12/06/2000 | EP1057828A2 Trovafloxacin oral suspensions |
| 12/06/2000 | EP1056879A1 Self-replicating vector for dna immunization against hiv |
| 12/06/2000 | EP1056877A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 12/06/2000 | EP1056865A2 Leptospiral outer membrane protein, lipl32 |
| 12/06/2000 | EP1056843A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 12/06/2000 | EP1056842A2 Genetic vaccine vector engineering |
| 12/06/2000 | EP1056834A2 Apoptotic cell-mediated antigen presentation to dendritic cells |
| 12/06/2000 | EP1056781A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
| 12/06/2000 | EP1056771A1 Streptogramin derivatives, preparation method and compositions containing same |
| 12/06/2000 | EP1056762A1 Genetic immunization with nonstructural proteins of hepatitis c virus |
| 12/06/2000 | EP1056761A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE |
| 12/06/2000 | EP1056742A1 Anti-viral pyrimidine derivatives |
| 12/06/2000 | EP1056722A1 Bisulfate salt of hiv protease inhibitor |
| 12/06/2000 | EP1056718A1 Anti-retroviral functionalised aromatic compounds |
| 12/06/2000 | EP1056476A1 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions |
| 12/06/2000 | EP1056470A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 12/06/2000 | EP1056465A1 Antimicrobial peptides and derived metapeptides |
| 12/06/2000 | EP1056458A1 Method for the treatment of pain, including chronic and female specific pain |
| 12/06/2000 | EP1056443A1 Butorphanol sustained release formulations |
| 12/06/2000 | EP0591303B1 Methods and compositions for treating malaria and other diseases |
| 12/06/2000 | CN1275983A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV) |
| 12/06/2000 | CN1275914A Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 12/06/2000 | CN1275885A Precise efficary assay methods for active agents including chemotherapeutic agents |
| 12/06/2000 | CN1275385A Medicinal composition for treating beriberi and preparation process thereof |
| 12/06/2000 | CN1275380A Medicine pill for detoxicating, killing bacteria and relieving inflammation |
| 12/06/2000 | CN1275378A Medicinal bait of bolbstemmatoside B for preventing and controlling haman and animal viral disease |
| 12/06/2000 | CN1275376A Hydroxy diphenyl ether compound |
| 12/06/2000 | CN1275346A Method and equipment for destructive distillation of haw kernel to extract juice |
| 12/06/2000 | CN1059213C Preparation of d4T from 5-methyluridine |
| 12/06/2000 | CN1059212C 9-N-ethenyl derivatives of 9 (S)-erythromycylamine |
| 12/06/2000 | CN1059122C Antipyretic and antitoxic particles and preparation process thereof |
| 12/06/2000 | CN1059121C Traditional Chinese medicinal capsule for treating pulmonary tuberculosis |
| 12/06/2000 | CN1059088C Powder preparation for healing damaged skin |
| 12/06/2000 | CN1059086C Anti-beta-lactamase antibiotic composition |
| 12/05/2000 | US6156903 Pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components |
| 12/05/2000 | US6156887 Compositions and methods for the treatment and diagnosis of immune disorders |
| 12/05/2000 | US6156878 Amino acid sequences; for antibodies, immunosuppressants, immunomodulators, immunotoxins, and diagnosis of related disorders |
| 12/05/2000 | US6156779 Fungicides against candida |
| 12/05/2000 | US6156774 Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors |
| 12/05/2000 | US6156759 Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and method for use thereof |
| 12/05/2000 | US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 12/05/2000 | US6156737 Therapy for hepatitis b |
| 12/05/2000 | US6156734 Cardiovascular disorders |
| 12/05/2000 | US6156730 Anti-fungal peptides |
| 12/05/2000 | US6156558 Alphavirus RNA replicon systems |
| 12/05/2000 | US6156541 Compositions and methods for catalyzing hydrolysis of HIV gp120 |
| 12/05/2000 | US6156535 Nucleotide sequences coding inhibitor of apoptosis protein; for diagnosing a cell proliferation defect |
| 12/05/2000 | US6156534 Producing antibiotic cefprozil, cefadroxil or amoxicillin by reacting penicillin or cephalosporin derivitive with 4-hydroxy-d-phenylglycyl ester in presence of penicillin g amidase |
| 12/05/2000 | US6156525 Method for judging eradication of H. pylori based on rates of changes in the pepsinogen I/II ratio |
| 12/05/2000 | US6156523 Serine/threonine protein kinases |
| 12/05/2000 | US6156496 Suppressing microorganism propagation in eukaryotic cell; administering a blocking agent to cells to prevent suppression of kinase activity |
| 12/05/2000 | US6156495 Kit for detecting the presence of microorganism antigen in humans; for the development of vaccines against viral diseases |
| 12/05/2000 | US6156349 Method of treating HIV infection with suppository containing mammalian liver extract |
| 12/05/2000 | US6156346 Urease-responsive delivery systems for diagnostic and therapeutic applications |
| 12/05/2000 | US6156320 Adminstering lactobacillus culture |
| 12/05/2000 | US6156319 Polypeptide |
| 12/05/2000 | US6156317 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 12/05/2000 | US6156314 Monoclonal antibodies |
| 12/05/2000 | US6156310 Isolated polypeptide |
| 12/05/2000 | US6156302 Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes |
| 12/05/2000 | US6155266 Stimulating the production of natural killer cells to destroy tumor cells by administering interferons and a histamine receptors agonist |
| 12/04/2000 | CA2311112A1 Trovafloxacin oral suspensions |
| 11/30/2000 | WO2000071737A2 Improved retroviral production by inhibition of the enveloppe cell receptor |
| 11/30/2000 | WO2000071736A1 Isoflavonoid methylation enzyme |
| 11/30/2000 | WO2000071725A2 Combination neisserial compositions |
| 11/30/2000 | WO2000071693A2 Method for selecting improved vectors |
| 11/30/2000 | WO2000071585A1 Human antibodies to staphylococcus aureus |
| 11/30/2000 | WO2000071584A1 Seven transmembrane receptor genes |
| 11/30/2000 | WO2000071574A2 Antigenic neisserial peptides |
| 11/30/2000 | WO2000071561A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 11/30/2000 | WO2000071560A1 Methods of modulating activity of prokaryotic ribosomes |
| 11/30/2000 | WO2000071557A1 13-methyl-erythromycin derivatives |